J Korean Assoc Oral Maxillofac Surg.  2013 Dec;39(6):255-256. 10.5125/jkaoms.2013.39.6.255.

Growth factors in oral and maxillofacial surgery: potentials and challenges

• Lee BK

• KMID: 1960973
• DOI: http://doi.org/10.5125/jkaoms.2013.39.6.255

Abstract

No abstract available.

MeSH Terms

Intercellular Signaling Peptides and Proteins*
Surgery, Oral*
Intercellular Signaling Peptides and Proteins

Reference

1. Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface. 2011; 8:153–170. PMID: 20719768.

2. Payne KF, Balasundaram I, Deb S, Di Silvio L, Fan KF. Tissue 256engineering technology and its possible applications in oral and maxillofacial surgery. Br J Oral Maxillofac Surg. 2013; pii: S0266-4356(13)00094-6.

3. Chanchareonsook N, Junker R, Jongpaiboonkit L, Jansen JA. Tissue-engineered mandibular bone reconstruction for continuity defects: a systematic approach to the literature. Tissue Eng Part B Rev. 2013; [Epub ahead of print].

4. Cicciù M, Herford AS, Juodžbalys G, Stoffella E. Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw. J Craniofac Surg. 2012; 23:784–788. PMID: 22565901.

5. Spagnoli DB, Marx RE. Dental implants and the use of rhBMP-2. Oral Maxillofac Surg Clin North Am. 2011; 23:347–361. PMID: 21492806.

6. Janssen NG, Weijs WL, Koole R, Rosenberg AJ, Meijer GJ. Tissue engineering strategies for alveolar cleft reconstruction: a systematic review of the literature. Clin Oral Investig. 2013; [Epub ahead of print].

7. Ripamonti U, Tsiridis E, Ferretti C, Kerawala CJ, Mantalaris A, Heliotis M. Perspectives in regenerative medicine and tissue engineering of bone. Br J Oral Maxillofac Surg. 2011; 49:507–509. PMID: 21144628.